Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Betting on an Ambrella (AMBA) Recovery? Exercise Caution

By Chris Lau, InvestorPlace Contributor

Ambarella (AMBA) snapped back from a selloff following its quarterly earnings report, but the company still has lots to prove to investors

Why Tesla (TSLA) Should Replace Nvidia with Intel for Infotainment

By Chris Lau, InvestorPlace Contributor

Rumors of Tesla's (TSLA) move to replace Nvidia (NVDA) with Intel (INTC) parts makes perfect sense, not just on the potential cost-savings.

Micron Technology, Inc. (MU) Stock Is Cheap and Has a Very Bright Future

By Chris Lau, InvestorPlace Contributor

Micron continues to attract investor attention. Even at new yearly highs, MU stock trades at below-average forward multiples.

Apple Inc. (AAPL) Stock Edges Toward Trillion-Dollar Market Cap

By Chris Lau, InvestorPlace Contributor

Apple (AAPL) edges closer to a trillion-dollar market cap. Fueling AAPL stock is the company's burgeoning Services unit.

Qualcomm, Inc. (QCOM) Stock Is Perfect for Patient Value Investors

By Chris Lau, InvestorPlace Contributor

Qualcomm has strong growth ahead with its Snapdragon chips and its impending NXP buyout, but QCOM stock isn't trading that way.

Load More